EP4100744A4 - DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION - Google Patents

DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION Download PDF

Info

Publication number
EP4100744A4
EP4100744A4 EP21750486.9A EP21750486A EP4100744A4 EP 4100744 A4 EP4100744 A4 EP 4100744A4 EP 21750486 A EP21750486 A EP 21750486A EP 4100744 A4 EP4100744 A4 EP 4100744A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
cytomegalovirus infection
congenital cytomegalovirus
congenital
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21750486.9A
Other languages
German (de)
French (fr)
Other versions
EP4100744A1 (en
Inventor
Dana WOLF
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hadasit Medical Research Services and Development Co
Original Assignee
Hadasit Medical Research Services and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Medical Research Services and Development Co filed Critical Hadasit Medical Research Services and Development Co
Publication of EP4100744A1 publication Critical patent/EP4100744A1/en
Publication of EP4100744A4 publication Critical patent/EP4100744A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steam Or Hot-Water Central Heating Systems (AREA)
EP21750486.9A 2020-02-03 2021-02-03 DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION Pending EP4100744A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062969176P 2020-02-03 2020-02-03
PCT/IL2021/050125 WO2021156860A1 (en) 2020-02-03 2021-02-03 Diagnosis of congenital cytomegalovirus infection

Publications (2)

Publication Number Publication Date
EP4100744A1 EP4100744A1 (en) 2022-12-14
EP4100744A4 true EP4100744A4 (en) 2024-07-24

Family

ID=77199756

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21750486.9A Pending EP4100744A4 (en) 2020-02-03 2021-02-03 DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION

Country Status (5)

Country Link
EP (1) EP4100744A4 (en)
AU (1) AU2021217240A1 (en)
CA (1) CA3169402A1 (en)
IL (1) IL295233A (en)
WO (1) WO2021156860A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
US9261505B2 (en) * 2007-10-22 2016-02-16 The Regents Of The University Of California Biomarkers for prenatal diagnosis of congenital cytomegalovirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8450069B2 (en) * 2009-06-08 2013-05-28 Singulex, Inc. Highly sensitive biomarker panels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9261505B2 (en) * 2007-10-22 2016-02-16 The Regents Of The University Of California Biomarkers for prenatal diagnosis of congenital cytomegalovirus
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021156860A1 *
VILLARROYA JOAN ET AL: "Secretory Proteome of Brown Adipocytes in Response to cAMP-Mediated Thermogenic Activation", FRONTIERS IN PHYSIOLOGY, vol. 10, 7 February 2019 (2019-02-07), CH, XP093121804, ISSN: 1664-042X, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374321/pdf/fphys-10-00067.pdf> DOI: 10.3389/fphys.2019.00067 *
VORONTSOV OLESYA ET AL: "Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 132, no. 11, 1 June 2022 (2022-06-01), US, XP093121736, ISSN: 1558-8238, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151692/pdf/jci-132-157415.pdf> DOI: 10.1172/JCI157415 *

Also Published As

Publication number Publication date
AU2021217240A1 (en) 2022-09-22
WO2021156860A1 (en) 2021-08-12
CA3169402A1 (en) 2021-08-12
IL295233A (en) 2022-10-01
EP4100744A1 (en) 2022-12-14

Similar Documents

Publication Publication Date Title
FR22C1063I2 (en) THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF HIV VIRUS INFECTION
EP4143207A4 (en) VACCINE COMPOSITION FOR THE PREVENTION OR TREATMENT OF SARS-COV-2 INFECTION
EP3813634A4 (en) ARTICULATION OF MEDICAL INSTRUMENTS
LT4445900T (en) THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF HIV VIRUS INFECTION
EP2646043A4 (en) NEW CICLOSPORINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION
EP3405183A4 (en) ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTION
EP3414573A4 (en) NOVEL MONOCLONAL ANTI-LAM AND ANTI-PIM6 / LAM ANTIBODIES FOR THE DIAGNOSIS AND TREATMENT OF KOCH BACILLUS INFECTIONS
EP3607091A4 (en) HUMAN IGM CONSTANT REGIONS MODIFIED FOR THE MODULATION OF THE COMPLEMENT DEPENDENT CYTOLYTIC EFFECTOR FUNCTION
MA46490A1 (en) Substituted 4&#39;- fluoro-2 &#39;- methyl nucleoside derivatives
EP4255845A4 (en) MULTI-AXIS MEDICAL IMAGING
EP4301132A4 (en) ROCK2 INHIBITOR FOR THE TREATMENT OF VIRAL INFECTION
EP3999121A4 (en) TREATMENT/PREVENTION OF DISEASE BY INHIBITION OF LING COMPLEX
EP3837277A4 (en) RECOMBINANT NEWCASTLE DISEASE VIRUSES AND THEIR USES FOR THE PREVENTION OF RSV DISEASE OR HUMAN METAPNEUMOVIRUS DISEASE
EP3817750A4 (en) COMPOSITIONS OF CANNABIDIOL ASSOCIATIONS
EP4203781A4 (en) BLOOD FLOW IMAGING
EP4259822A4 (en) SINGLE BUFFER COMPOSITIONS FOR THE DETECTION OF NUCLEIC ACIDS
EP4100744A4 (en) DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION
EP4178614A4 (en) COMPOSITIONS AND METHODS OF DIAGNOSIS AND TREATMENT OF SARS-COV-2 VIRUS INFECTION
EP3785718A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN INFECTIOUS FLAVIVIRUS DISEASE
EP3406262A4 (en) SPECIFIC MONOCLONAL ANTIBODIES OF HUMAN ADENOVIRUS (ADV) PIII ANTIGEN, PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY ADV
EP4072587A4 (en) DEBARYOMYCES SPECIES AS AN INDICATOR OF NON-HEALING ULCERS IN CROHN’S DISEASE
EP3892331A4 (en) COMPOSITION FOR THE SUPPRESSION OF NOROVIRUS INFECTION
EP3953485A4 (en) MODULATION OF HTRA1 FOR THE TREATMENT OF ARMD
EP3936618A4 (en) METHOD AND KIT FOR DETECTION OF INFLUENZA VIRUS AND METHOD FOR DIAGNOSIS OF INFECTION BY INFLUENZA VIRUS
EP4121403A4 (en) NITRO-AMINOADAMANTANE COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220904

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101AFI20240129BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20240625

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/569 20060101ALI20240619BHEP

Ipc: G01N 33/68 20060101AFI20240619BHEP